Genomics And Proteomics Reagents, Research Kits and Analytical Instruments Market to Reach US$52.3 bn by the End 2019

The global Genomics And Proteomics Reagents, Research Kits And Analytical Instruments Market is highly fragmented, in terms of vendor landscape, states a new research study by Transparency Market Research (TMR). Some of the leading market players, such as Sigma Aldrich, Illumina, Thermo Fisher, and Waters and Life Technologies have been keen on expanding their businesses overseas and, owing to this, they have continued to actively participate in raising awareness among consumers about analytical tools that can assist in identifying and controlling the spread of pandemic and endemic diseases across the world. Over the coming years, they are likely to focus more on mergers and acquisitions to support their expansion plans, notes the market study.

As per the research study, the global genomics and proteomics reagents, research kits and analytical instruments is anticipated to register an exponential CAGR of 12.10% during the period from 2013 to 2019 and increase from US$23.8 bn in 2012 to US$52.3 bn by the end of the period of the forecast. The market is mainly segmented into two broad areas, i.e., the genomics and proteomics reagent kits segment and the genomics and proteomics analytical tools segment.

The former deals with the products utilized in the preparation of the sample, purification and isolation, lab-on-chip applications, electrophoresis, and biochips or microarrays while the genomics and proteomics analytical tools segment deals with the products used in chromatography, thermal cyclers for PCR applications, mass spectrometry, and next generation sequencers, states the research report.

Request to View Sample of Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=983

The global market for genomics and proteomics reagents, research kits and analytical instruments is gaining significantly from the ongoing rise in clinical and preclinical research to identify new diseases and develop novel drugs for their treatment. The considerable increase in the prevalence of diabetes, cancer, and a host of other genetic diseases has also opened new revenue streams for market players. Over the coming years, the increasing demand for these kits and tools from the agriculture sector and the forensic industry is anticipated to support the growth of this market, substantially, states the market report.

Leave a Reply